HyperTETS/D (GRIFOLS USA, LLC)


Welcome to the PulseAid listing for the HyperTET drug offered from GRIFOLS USA, LLC. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: GRIFOLS USA, LLC
NON-PROPRIETARY NAME: Tetanus Immune Globulin (Human)
SUBSTANCE NAME: HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1996-08-14
END MARKETING DATE: 0000-00-00


HyperTET S/D PLASMA DERIVATIVE Details:

Item DescriptionHyperTET S/D from GRIFOLS USA, LLC
LABELER NAME: GRIFOLS USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 250([iU]/mL)
START MARKETING DATE: 1996-08-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 13533-634_837a9dc8-28c8-48af-b18b-1620f67c7527
PRODUCT NDC: 13533-634
APPLICATION NUMBER: BLA101142

Other HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GRIFOLS USA, LLCHyperTET